New Delhi: The UNAIDS 2025 worldwide AIDS replace, titled “AIDS, crisis And The power to transform”, raises alarm over widening investment gaps inside the fight towards HIV, as international locations like India retain to conflict deep-rooted stigma, discrimination, and gender-based totally violence.

The document, released on 10 July, reveals that almost 30% of Indians aged 15–forty nine stated experiencing HIV-associated stigma and discrimination between 2020 and 2024. Disturbingly, 24% of partnered or married Indian women dwelling with HIV on this age organization suggested facing intimate partner violence, most effectively 10% decrease than Liberia, the use of a with the highest charge globally.

Gender inequality additionally persists. Over 8% of Indian ladies aged 15,49 lacked autonomy over sexual and reproductive choices, at the same time as more than 9% lacked admission to adequate information about contraceptives.

Regardless of an international reduction in new HIV infections (by using 40%) and HIV-related deaths (by using 56%) for the reason that 2010, UNAIDS executive Director Winnie Byanyima warns that shrinking worldwide help, especially the capacity withdrawal of the U.S. President’s Emergency Plan for AIDS relief (PEPFAR), could result in 6 million new infections and four million additional deaths by 2029.

The report notes that the funding disaster has already disrupted remedy and prevention programmes globally. Yet, hope remains in innovations like Lenacapavir, a protracted-performing injectable PrEP with close-to-complete efficacy in clinical trials. Though Gilead Sciences has certified six usual producers, along with India-based totally Dr. Reddy’s, Emcure, Hetero, and Mylan (a Viatris subsidiary), affordability and accessibility continue to be fundamental hurdles.

Regionally, Japanese and Southern Africa recorded the highest number of new HIV infections in 2024 (37%), followed by Asia and the Pacific, which include India, at 23%. In terms of humans residing with HIV, Africa leads with 21.1 million, while Asia-Pacific debts for 6.9 million.

India is one in all thirteen out of 35 reporting countries to gain secure injecting objectives, with 90% of users using sterile devices. It is also indexed as a “Low-Dependency U.S.” on PEPFAR investment, alongside South Africa, Brazil, and Thailand.

The record highlights how social firms in India are assisting sustain HIV services. As an example, the Mist LGBTQ basis offers unfastened or low-fee HIV self-trying out and PrEP consultations through its online platform. Similarly, TAAL+ Pharmacy, run by the network of Maharashtra human beings dwelling with HIV, sells discounted antiretroviral and essential drugs via corporate social duty projects.

UNAIDS concludes that ultimate the funding gap and increasing get entry to to new prevention tools are crucial to reversing the epidemic and ensuring equitable healthcare get right of entry to for all.

Sources

https://theprint.in/health/unaids-2025-report-warns-of-funding-gaps-in-fight-against-hiv-as-india-battles-stigma-discrimination/2688970/?amp

https://www.unaids.org/en/UNAIDS-global-AIDS-update-2025